Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: A study based on mRNA analysis and immunohistochemistry

Clinical Endocrinology

Volumn 66, Issue 3, 2007, Pages 335-340

  Hofland, J ^a   Van Nederveen, F H ^a   Timmerman, M A ^a   Korpershoek, E ^a   De Herder, W W ^a   Lenders, J W ^b   Verhofstad, A A ^b   De Krijger, R R ^a   De Jong, F H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; ACTIVIN RECEPTOR 2A; ACTIVIN RECEPTOR 2B; ACTIVIN RECEPTOR LIKE KINASE 4; BETAGLYCAN; BINDING PROTEIN; FOLLISTATIN; GROWTH FACTOR RECEPTOR; INHIBIN; INHIBIN ALPHA SUBUNIT; INHIBIN BETA A SUBUNIT; INHIBIN BETA B SUBUNIT; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ADRENAL GLAND NEOPLASMS; ADULT; BLOTTING, NORTHERN; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLISTATIN; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; INHIBINS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 33846939508     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02732.x     Document Type: Article

References (32)

1. Bravo, E.L. (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocrine Reviews, 15, 356-368.
2. Proye, C.A., Vix, M., Jansson, S., Tisell, L.E., Dralle, H. & Hiller, W. (1994) 'The' pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World Journal of Surgery, 18, 467-472.
3. Thompson, L.D. (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. American Journal of Surgical Pathology, 26, 551-566.
4. van der Harst, E., Bruining, H.A., Bonjer, H.J., van der Ham, F., Dinjens, W.N., Lamberts, S.W., de Herder, W.W., Koper, J.W., Stijnen, T., Proye, C., Lecomte-Houcke, M., Bosman, F.T. & de Krijger, R.R. (2000) Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? Journal of Pathology, 191, 175-180.
5. Dannenberg, H., Speel, E.J., Zhao, J., Saremaslani, P., van Der Harst, E., Roth, J., Heitz, P.U., Bonjer, H.J., Dinjens, W.N., Mooi, W.J., Komminoth, P. & de Krijger, R.R. (2000) Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. American Journal of Pathology, 157, 353-359.
6. Neumann, H.P., Pawlu, C., Peczkowska, M., Bausch, B., McWhinney, S.R., Muresan, M., Buchta, M., Franke, G., Klisch, J., Bley, T.A., Hoegerle, S., Boedeker, C.C., Opocher, G., Schipper, J., Januszewicz, A. & Eng, C. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association, 292, 943-951.
7. Gimenez-Roqueplo, A.P., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Khau Van Kien, P., Corvol, P., Plouin, P.F. & Jeunemaitre, X. (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research, 63, 5615-5621.
8. Eisenhofer, G., Bornstein, S.R., Brouwers, F.M., Cheung, N.K., Dahia, P.L., de Krijger, R.R., Giordano, T.J., Greene, L.A., Goldstein, D.S., Lehnert, H., Manger, W.M., Maris, J.M., Neumann, H.P., Pacak, K., Shulkin, B.L., Smith, D.I., Tischler, A.S. & Young, W.F. Jr (2004) Malignant pheochromocytoma: current status and initiatives for future progress. Endocrine Related Cancer, 11, 423-436.
9. de Krijger, R.R., van der Harst, E., van der Ham, F., Stijnen, T., Dinjens, W.N., Koper, J.W., Bruining, H.A., Lamberts, S.W. & Bosman, F.T. (1999) Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas. Journal of Pathology, 188, 51-55.
10. Salmenkivi, K., Arola, J., Voutilainen, R., Ilvesmaki, V., Haglund, C., Kahri, A.I., Heikkila, P. & Liu, J. (2001) Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis. Journal of Clinical Endocrinology and Metabolism, 86, 2231-2235.
11. Ling, N., Ying, S.Y., Ueno, N., Shimasaki, S., Esch, F., Hotta, M. & Guillemin, R. (1986) Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature, 321, 779-782.
12. Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D. & Spiess, J. (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature, 321, 776-779.
13. de Kretser, D.M., Meinhardt, A., Meehan, T., Phillips, D.J., O'Bryan, M.K. & Loveland, K.A. (2000) The roles of inhibin and related peptides in gonadal function. Molecular and Cellular Endocrinology, 161, 43-46.
14. Pangas, S.A. & Woodruff, T.K. (2000) Activin signal transduction pathways. Trends in Endocrinology and Metabolism, 11, 309-314.
15. Martens, J.W., de Winter, J.P., Timmerman, M.A., McLuskey, A., van Schaik, R.H., Themmen, A.P. & de Jong, F.H. (1997) Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells. Endocrinology, 138, 2928-2936.
16. Lewis, K.A., Gray, P.C., Blount, A.L., MacConell, L.A., Wiater, E., Bilezikjian, L.M. & Vale, W. (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature, 404, 411-414.
17. Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K. & Sugino, H. (1990) Activin-binding protein from rat ovary is follistatin. Science, 247, 836-838.
18. McCluggage, W.G., Burton, J., Maxwell, P. & Sloan, J.M. (1998) Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. Journal of Clinical Pathology, 51, 114-116.
19. Arola, J., Liu, J., Heikkila, P., Ilvesmaki, V., Salmenkivi, K., Voutilainen, R. & Kahri, A.I. (2000) Expression of inhibin α in adrenocortical tumours reflects the hormonal status of the neoplasm. Journal of Endocrinology, 165, 223-229.
20. Cho, E.Y. & Ahn, G.H. (2001) Immunoexpression of inhibin alpha-subunit in adrenal neoplasms. Applied Immunohistochemistry and Molecular Morphology, 9, 222-228.
21. Pelkey, T.J., Frierson, H.F. Jr, Mills, S.E. & Stoler, M.H. (1998) The alpha subunit of inhibin in adrenal cortical neoplasia. Modern Pathology, 11, 516-524.
22. Zhang, P.J., Genega, E.M., Tomaszewski, J.E., Pasha, T.L. & LiVolsi, V.A. (2003) The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Modern Pathology, 16, 591-597.
23. Iwasaki, S., Hattori, A., Sato, M., Tsujimoto, M. & Kohno, M. (1996) Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. Journal of Biological Chemistry, 271, 17 360-17 365.
24. Paralkar, V.M. & Weeks, B.S., Yu, Y.M., Kleinman, H.K. & Reddi, A.H. (1992) Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. Journal of Cell Biology, 119, 1721-1728.
25. Liu, J., Heikkila, P., Kahri, A.I. & Voutilainen, R. (2000) Expression of activin A and its receptors in human pheochromocytomas. Journal of Endocrinology, 165, 503-508.
26. Silva, C.C., Groome, N.P. & Knight, P.G. (2003) Immunohistochemical localization of inhibin/activin α, βA and βB subunits and follistatin in bovine oocytes during in vitro maturation and fertilization. Reproduction, 125, 33-42.
27. Hofland, J., Timmerman, M.A., de Herder, W.W., van Schaik, R.H.N., de Krijger, R.R. & de Jong, F.H. (2006) Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms. Clinical Endocrinology, 65, 792-799.
28. Tricarico, C., Pinzani, P., Bianchi, S., Paglierani, M., Distante, V., Pazzagli, M., Bustin, S.A. & Orlando, C. (2002) Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Analytical Biochemistry, 309, 293-300.
29. Spencer, S.J., Rabinovici, J., Mesiano, S., Goldsmith, P.C. & Jaffe, R.B. (1992) Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. Journal of Clinical Investigation, 90, 142-149.
30. Wang, E.Y., Ma, E.Y. & Woodruff, T.K. (2003) Activin signal transduction in the fetal rat adrenal gland and in human H295R cells. Journal of Endocrinology, 178, 137-148.
31. Fogt, F., Zimmerman, R.L., Mulligan, N., Vortmeyer, A.O., Poremba, C., Harris, C.A., Alsaigh, N., Tomaszewski, J.E. & Nikulasson, S.T. (1999) BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study. International Journal of Molecular Medicine, 3, 271-274.
32. Bornstein, S.R., Gonzalez-Hernandez, J.A., Ehrhart-Bornstein, M., Adler, G. & Scherbaum, W.A. (1994) Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. Journal of Clinical Endocrinology and Metabolism, 78, 225-232.